Takeda Pharmaceutical Company (TAKN) Q2 2024 Earnings Report
MX:TAKN Q2 2024 EPS Results
- Actual EPS
- MXN 3.57
- Consensus EPS
- MXN 2.33
- Beat/Miss
- Beat by +MXN 1.24
- One Year Ago EPS
- -MXN 1.95
MX:TAKN Q2 2024 Revenue Results
- Actual Revenue
- MXN 148.04B
- Expected Revenue
- MXN 139.99B
- Beat/Miss
- Beat by +MXN 8.05B
- YoY Revenue Growth
- +9.21%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 10/31/2024
- Time
- Before Open
- Conference Call
- Thursday, October 31, 2024
MX:TAKN Upcoming Earnings
Takeda Pharmaceutical Company's next earnings date is estimated for January 28, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
MX:TAKN Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:TAKN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Jan 28, 2027 | 2026 (Q3) | 5.30- | 4 | ― | ― |
| Oct 29, 2026 | 2026 (Q2) | 2.727.21 | -0.47 | 1636.00% (+7.68) | |
| Jul 30, 2026 | 2026 (Q1) | 3.174.23 | 4.96 | -14.77% (-0.73) | |
| May 13, 2026 | 2025 (Q4) | -1.41-0.92 | -4.28 | 78.51% (+3.36) | |
| Jan 29, 2026 | 2025 (Q3) | 2.554.00 | 0.92 | 334.69% (+3.08) | |
| Oct 30, 2025 | 2025 (Q2) | 1.32-0.47 | 3.57 | -113.16% (-4.04) | |
| Jul 29, 2025 | 2025 (Q1) | 3.194.96 | 3.81 | 30.05% (+1.15) | |
| May 08, 2025 | 2024 (Q4) | -0.53-4.28 | -0.13 | -3157.14% (-4.15) | |
| Jan 30, 2025 | 2024 (Q3) | 1.600.92 | 4.28 | -78.51% (-3.36) | |
| Oct 31, 2024 | 2024 (Q2) | 2.333.57 | -1.95 | 282.69% (+5.52) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed